Chargement en cours...
Lymphocyte activation gene-3 (LAG-3, CD223) in plasmacytoid dendritic cells (pDCs): a molecular target for the restoration of active antitumor immunity
We have recently reported that lymphocyte activation gene-3 (LAG-3,CD223) mediates the alternative, IFNα-deficient activation of plasmacytoid dendritic cells (pDCs) at tumor sites. Our findings define a novel tumor-driven strategy that promotes immunosuppression by pDCs, and we have provided more de...
Enregistré dans:
| Publié dans: | Oncoimmunology |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4292561/ https://ncbi.nlm.nih.gov/pubmed/25941596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.967146 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|